Evidence map›Paper›PMID 22542182›Full record

ArticleNeuron2012

Regulation of presynaptic neurotransmission by macroautophagy.

Daniela Hernandez, Ciara A Torres, Wanda Setlik, Carolina Cebrián, Eugene V Mosharov, Guomei Tang, Hsiao-Chun Cheng, Nikolai Kholodilov, Olga Yarygina, Robert E Burke and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Neuron, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 205 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
205citing papers in PubMed, 1 pooled it
10.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

205 citing papers in PubMed, 1 synthesis or guideline pooled it, 340 citations in OpenAlex.

  1. Pooled it
  2. Synaptic Proteostasis in Health and Disease.Journal of neurochemistry · 2026
    Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Condition-dependent effects of knockdown of autophagy onbioRxiv : the preprint server for biology · 2025
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review

145 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Daniela HernandezDepartment of Neuroscience, Columbia University Medical Campus, New York, NY 10013, USA.
Ciara A Torres
Wanda Setlik
Carolina Cebrián
Eugene V Mosharov
Guomei Tang
Hsiao-Chun Cheng
Nikolai Kholodilov
Olga Yarygina
Robert E Burke
Michael Gershon
David Sulzer
Columbia University Irving Medical Center · US

Funding

TRANSLATIONAL APPROACHES TO NEUROPROTECTION OF AXONS IN PDrP50NS038370 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI BURKE, ROBERT E · 1999 to 2014
$24.0M
The Presynaptic Vesicle Cycle for the Slow Acting Neurotransmitter SecretionP01DA010154 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI EDWARDS, ROBERT H, KREITZER, ANATOL · 1995 to 2016
$14.7M
TRAINING IN CELLULAR, MOLECULAR AND BIOPHYSICAL STUDIEST32GM008224 · NIGMS · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI LIEM, RONALD K. · 1987 to 2021
$9.9M
The Dopamine Synapse and Associative LearningR01DA007418 · NIDA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI David Sulzer · 1999 to 2026
$9.4M
Interaction between DA, alpha-Synuclein and Chaperone-Mediated AutophagyR01NS075222 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MOSHAROV, EUGENE V · 2011 to 2015
$1.7M
Spectra-Physics Mai Tai HP LaserS10RR026895 · NCRR · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SULZER, DAVID · 2010 to 2010
$196k
AMPHETAMINE ACTION MESOLIMBIC DOPAMINE NEURONAL CULTURER29DA007418 · NIDA · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI SULZER, DAVID · 1991 to 1995
–
AMPHETAMINE ACTION IN MIDBRAIN DOPAMINE NEURONAL CULTURER55DA007418 · NIDA · NEW YORK STATE PSYCHIATRIC INSTITUTE · PI SULZER, DAVID · 1996 to 1996
–
NCRR NIH HHS S10 RR026895NIDA NIH HHS DA07418NIDA NIH HHS DA10154NIDA NIH HHS P01 DA010154NIDA NIH HHS R01 DA007418NIGMS NIH HHS T32 GM008224NINDS NIH HHS P50 NS038370NINDS NIH HHS R01 NS075222
6 · The paper itself

Abstract

mTOR is a regulator of cell growth and survival, protein synthesis-dependent synaptic plasticity, and autophagic degradation of cellular components. When triggered by mTOR inactivation, macroautophagy degrades long-lived proteins and organelles via sequestration into autophagic vacuoles. mTOR further regulates synaptic plasticity, and neurodegeneration occurs when macroautophagy is deficient. It is nevertheless unknown whether macroautophagy modulates presynaptic function. We find that the mTOR inhibitor rapamycin induces formation of autophagic vacuoles in prejunctional dopaminergic axons with associated decreased axonal profile volumes, synaptic vesicle numbers, and evoked dopamine release. Evoked dopamine secretion was enhanced and recovery was accelerated in transgenic mice in which macroautophagy deficiency was restricted to dopaminergic neurons; rapamycin failed to decrease evoked dopamine release in the striatum of these mice. Macroautophagy that follows mTOR inhibition in presynaptic terminals, therefore, rapidly alters presynaptic structure and neurotransmission.

Indexed as

8-Hydroxy-2-(di-n-propylamino)tetralinAnalysis of VarianceAnimalsAutophagyAutophagy-Related Protein 7Behavior, AnimalBrainCorpus StriatumDopamineDopamine Plasma Membrane Transport ProteinsElectrochemistryGene Expression RegulationGenotypeImmunosuppressive AgentsIn Vitro TechniquesMale5-hydroxy-2-N,N-dipropylaminotetralin8-Hydroxy-2-(di-n-propylamino)tetralinAtg7 protein, mouseAutophagy-Related Protein 7DopamineDopamine Plasma Membrane Transport ProteinsImmunosuppressive AgentsMap1lc3b protein, mouseMicrotubule-Associated ProteinsmTOR protein, mouseRNA, MessengerSirolimusTOR Serine-Threonine KinasesTyrosine 3-Monooxygenase

Identifiers

PMID22542182
PMCPMC3578406
OpenAlexW2080967954

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.